Concepedia

Scott D. Collins

SD

12

Publications

1.8K

Citations

11

H-Index

1972

Active since

Affiliations

Mersana Therapeutics (United States)(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Scott D. Collins is an author at Mersana Therapeutics (United States) specializing in medicine, radiation oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

1972–2025

12

Publications

12

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations

, , +10

Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers

Joan T. Garrett, Cammie R. Sutton, Richard Kurupi et al. · Cancer Research · 2013 · 87 citations · Full text

Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers

Carl Uli Bialucha, Scott D. Collins, Xiao Li et al. · Cancer Discovery · 2017 · 52 citations · Full text

Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates

Jeremy R. Duvall, Joshua D. Thomas, Raghida A. Bukhalid et al. · Journal of Medicinal Chemistry · 2023 · 44 citations · Full text

HALOPERIDOL, CLOPENTHIXOL, AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIA

E. A. Serafetinides, Scott D. Collins, Mervin L. Clark · The Journal of Nervous and Mental Disease · 1972 · 41 citations

, , +12

Rows per page

1–5 of 12